Brief: Ionis Prices $700 Million Aggregate Principal Amount Of 0.00% Convertible Senior Notes Due 2030
13/11/2025 05:40
Nov 13 (Reuters) - Ionis Pharmaceuticals Inc IONS.O: IONIS PRICES CONVERTIBLE NOTES OFFERING TO REFINANCE 2026 CONVERTIBLE NOTES IONIS PHARMACEUTICALS INC: PRICING OF $700.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 0.00% CONVERTIBLE SENIOR NOTES DUE 2030 Source text: ID:nBw8Wm8HZa Further company coverage: IONS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Brief: Ionis Pharmaceuticals Says Ulefnersen Demonstrates Favorable Safety And Tolerability Profile
Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study